Ermenegildo Zegna Exhibit Celebrates 50th Anniversary of Brand’s Entry in RTW

MILAN — Who knew the Ermenegildo Zegna Group produced Emilio Pucci’s first men’s wear collection in 1968? And who knew Anna Zegna, president of Fondazione Zegna, worked with Gianni Versace on the designer’s first men’s collection in 1978?
These are only two of the surprising discoveries made during a preview tour of the exhibition “Uomini all’Italiana [Men Italian Style] 1968” staged at Casa Zegna, near the brand’s storied wool mill in Trivero, a one and a half hour drive from Milan. The exhibit, organized by Fondazione Zegna, celebrates the 50th anniversary of Ermenegildo Zegna’s entry into ready-to-wear and runs May 6 to Oct. 28. “These years were the beginning of the Italian fashion system and lifestyle,” said Anna Zegna. “Women’s wear was more established, while men’s wear was starting at that time.”

The Emilio Pucci jacket produced by Ermenegildo Zegna. 
Andrea Pisapia/

The exhibit also pays tribute to the namesake founder of the company, and to his sons, Angelo and Aldo. Ermenegildo Zegna first traveled to New York in 1938 to set up a branch, the Ermenegildo Zegna Corp., to meet Italian tailors, to work on direct distribution and “to fight the supremacy of English fabrics,” as claimed by a number of photos, ads and correspondence on

Follow WWD on Twitter or become a fan on Facebook.

Read More…


Ancient Roman Pantheon to start charging entry fee in 2018

ROME (Reuters) – Visitors to Rome’s Pantheon, one of the ancient world’s best preserved monuments, will have to pay an entry fee from next May unless they are going there to pray, Italy’s culture and tourism ministry said on Monday.

Reuters: Arts


Save anywhere from 35-55% off combined admission prices with the Explorer Pass from Smart Destinations!

UPDATE 2-CVS to start next-day delivery amid potential Amazon entry

Nov 6 (Reuters) – U.S. drugstore chain CVS Health Corp
said on Monday it would start next-day delivery from its
stores in 2018, a move some analysts said was in response to’s potential entry into prescription drug

Reuters: Company News


Find the Best Daily Deal in Your Neighborhood